Clinical Trials Browser

INDUSTRY × HLX07 × Tumor-Agnostic × Clear all

NCT02648490 2019-07-30

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers

Phase 1 Completed

Neoplasm Metastasis